Results For "

ruxolitinib manufacturer

": 3 Products Found

4-χλωρο-7-((2-(τριμεθυλοσιλλ) αιθοξυ) μεθυλο)-7H-πυρρόλο[2,3-d]πυριμιδίνη (941685-26-3)

4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine is used in the design and preparation of ruxolitinib. Product Name: 4-chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine CAS No.: 941685-26-3 Assay: 98% End Use: Ruxolitinib Molecular Formula: C12H18ClN3OSi Molecular Weight: 283.83 Shelf Life: 2 Years Package: 25kg/drum

Ρουξολιτινίμ Φωσφορικό (1092939-17- 7)

Ruxolitinib is an anti-tumor drug for the treatment of myeloproliferative neoplasm-associated myelofibrosis, further myeloproliferative neoplasms, polycythemia vera and refractory cancer. Product Name: Ruxolitinib Phosphate CAS No.: 1092939-17-7 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C17H21N6O4P Molecular Weight: 404.36 Shelf Life: 2 Years Package: 25kg/drum

3-κυλοπενθυλακρυλονιτρίλη (591769-05-0)

3-Cyclopentylacrylonitrile and its derivatives are used in the preparation of ruxolitinib intermediates and trasitinib phosphate. Product Name: 3-cyclopentylacrylonitrile CAS No.: 591769-05-0 Assay: 98% End Use: 591769-05-0 Molecular Formula: C9H12 Molecular Weight: 120.19 Shelf Life: 2 Years Package: 25kg/drum